was an interesting job, because I really knew nothing about their target market (B2B biomedical research and development). For a biotech startup in Los Angeles, they have had an incredible first two years, not only bringing their own products to market, but also winning major contracts for companies with Glaxo-Smith Kline and GE, amongst others.  

They did their best to explain 
engineered antibody fragments for 
Interior page.